Dr. Max Anderson received his dental
degree from the University of Nebraska (1976), his
Master of Science in Restorative Dentistry from The
University of Michigan (1983) and his Master of
Education from George Washington University (1988).
He completed a career in the Unites States Navy in
1990 and has served on the faculty of the University
of Washington and Indiana University. He served as
the Vice President and Dental Director of Washington
Dental Service (WDS) a Delta Dental Plan, in
Seattle, Washington from 1994 through 2004. His
primary research and academic interests are in the
management of dental diseases through treating these
diseases as bacterial infections and in the analysis
of insurance treatment data to identify best
practices on risk adjusted populations. He is
currently actively consulting regarding risk
assessed evidence based dental plan designs and
health outcomes.
Dr. Anderson continues his active role in the
professional organizations and public service with a
primary focus on operative dentistry and cariology.
He is the President and CEO of C3 Jian, Inc. a
California based biotechnology company developing
targeted antimicrobial drugs. Part of the company’s
research is contracted to and conducted at the
University of California at Los Angles. The company
is researching mechanisms to eradicate dental
caries, and other infectious diseases, through
intelligent drug design. He is the representative to
the American Dental Association’s Code Revision
Committee (CDT-2007 & CDT-2009) for Delta Dental
Plans Association and a member of its Dental Policy
Committee. He Chairs the ADA’s Standards Committee
on Dental Informatics Subcommittee on the dental
extension of the Continuity of Care Record which is
the patient referral record.
|
 |
